Patients | Controls | P | |
---|---|---|---|
Characteristics | |||
Sex | 0.133 | ||
Female | 59(29.2%) | 78(36.1) | |
Male | 143(70.8%) | 138(63.9) | |
Age yrs | 47.3 ± 19.4 | 48.5 ± 13.4 | 0.44 |
Smoking | |||
Smoking | 55(27.2%) | ND | |
Nonsmoking | 127(62.9%) | ND | |
Ever Smoking | 20(9.9%) | ND | |
Laboratory findings | |||
TP (65-85 g/L) | |||
< 65 | 49(24.3%) | 21(9.7%) | |
65–85 | 148(73.2%) | 195(90.3%) | |
ND | 5(2.5%) | 0 | |
Alb (40-55 g/L) | |||
< 40 | 85(42.1%) | 16(7.4%) | |
40–55 | 112(55.4%) | 200(92.6%) | |
ND | 5(2.5%) | 0 | |
TG (0.00–1.70 mm/L) | |||
0.00–1.70 | 148(73.3%) | 156(72.2%) | |
> 1.70 | 21(10.4%) | 60(27.8%) | |
ND | 33(16.3%) | 0 | |
TC (0.00–5.72 mm/L) | |||
0.00–5.72 | 149(73.8%) | 187(86.6%) | |
> 5.72 | 20(9.9%) | 29(13.4%) | |
ND | 33(16.3%) | 0 | |
LDL-C (0.00–3.64 mm/L) | |||
0.00–3.64 | 146(72.3%) | 171(79.2%) | |
> 3.64 | 23(11.4%) | 45(20.8%) | |
ND | 33(16.3%) | 0 | |
HDL-C (0.91–1.92 mm/L) | |||
< 0.91 | 78(38.6%) | 16(7.4%) | |
0.91–1.92 | 91(45.1%) | 189(87.5%) | |
> 1.92 | 0 | 11(5.1%) | |
ND | 33(16.3%) | 0 | |
ESR | |||
Increase | 148(73.3%) | ND | |
Normal | 40(19.8%) | ND | |
ND | 14(6.9%) | ND | |
Clinical phenotype | |||
Pulmonary tuberculosis | 202 | ||
Culture positive | 107(53.0%) | ND | |
Smear positive | 48(23.8%) | ND | |
Culture/smear positive | 47(23.2%) | ND | |
Radiographic findings | |||
Infiltrative PTB | 142(70.3%) | ND | |
Cavity PTB | 60(29.7%) | ND | |
System involvment | |||
TB pleurisy | 22(10.9%) | ND | |
Disseminated TB | 3(1.5%) | ND | |
Extra pulmonary involvement | 10(4.9%) | ND | |
None | 167(82.7%) | ND | |
Treatment times | |||
Initial treatment | 98(48.5%) | ND | |
Retreatment | 104(51.5%) | ND |